Welcome our new CFO and Head of M&A
🔔 Enosium Life Science welcomes Thibault Wirth as CFO and Head of M&A 🔔
We are thrilled to welcome Thibault Wirth as Chief Financial Officer (CFO) and Head of Mergers and Acquisitions (M&A) at Enosium Life Science. 🎉
🚀 A career shaped by M&A and entrepreneurship
With over 10 years of experience supporting small & mid-size companies, first as an advisor and then as an investor, Thibault brings essential skills and expertise needed for our growth.
Throughout his career, Thibault has supported executives and shareholders in their development and restructuring projects, both in France and internationally. He has worked closely with companies in different industries, with a particular focus on acquisition deals as well as integration and performance management.
Graduated from ESSEC Business School, Thibault began his career in investment banking, where he learned the ins and outs of mergers and acquisitions. He then joined a private equity fund specialized in value creation strategies, where he successfully executed several buyouts, led complex negotiations, and supported the strategic repositioning of companies. He notably spearheaded several external growth and market consolidation operations.
🤝 Expertise at the core of Enosium Life Science's strategy
Enosium Life Science aims to become a leading group in Europe providing consulting and services to the healthcare industry. Our ambition is to achieve several hundred million euros in revenue over the next five years through a Buy & Build strategy.
Backed by our strong financial partner Otium, we are able to bring together top entrepreneurs and highly specialized experts along the pharmaceutical value chain, from clinical research to commercialization.
As a key player of our acquisition strategy and operations, Thibault will be at the heart of Enosium Life Science’s value creation, overseeing the identification of the right companies to acquire, executing M&A processes, negotiating deals, and ensuring successful integrations.
"Thibault brings a wealth of technical knowledge, strategic insights, and a wonderful personality, making him a key player in the future success of our group," said Antoine Bassel Amer, CEO and Founder of Enosium Life Science.
